Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Realsil in subjects with hypertransaminasemia and steatosis or non-alcoholic steatohepatitis with or without HCV infection
2005-000860-24Phase 3Completed
- Sponsor
- Istituto Biochimico Italiano
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in metabolic dysfunction-associated steatohepatitis (MASH), steatosis and chronic hepatitis C (CHC) comparing Realsil with Placebo (2 arms). Started Aug 2005; status: completed.
02
Drugs
silybin + vitamin E + phospholipids
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)steatosischronic hepatitis C (CHC)
Beyond the preview
Go deeper on 2005-000860-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000860-24.